key: cord-1017414-cf3w8ubz
authors: nan
title: Letter to the editor in response to the article: “Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis (Kumar et al.)”
date: 2020-06-20
journal: Diabetes Metab Syndr
DOI: 10.1016/j.dsx.2020.06.005
sha: e6c71a4af6470effd50cddd31c5e4c8e4ef9059a
doc_id: 1017414
cord_uid: cf3w8ubz

nan

Dear Editor, We read the article by Kumar et al titled "Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis" https://doi.org/10.1016/j.dsx.2020.04.044 published on May 6, 2020 in this journal with a great interest [1] . We felt that authors have put more emphasis on strength of this analysis rather than the limitation. This meta-analysis has a lot more limitations than any strength, which should have been acknowledged by the authors.

We have noted following limitations to this meta-analysis, which needs kind attention of authors to interpret it properly.

1. Authors' have calculated the odds ratio of severity and mortality in patients with diabetes and COVID-19. However, to assess the relative risk of severity and mortality, risk ratio or hazard ratio should have been calculated, rather than the odds ratio. while conducting this meta-analysis and not excluded these studies to avoid overlapping data, that can lead to a wrong conclusion.

Manuscript File Click here to view linked References 3. Authors have concluded that "Diabetes in patients with COVID-19 is associated with a two-fold increase in mortality as well as severity of COVID-19, as compared to non-diabetics". This is a factually incorrect statement. Authors need to realize that they have calculated the odds ratio of severity and mortality while comparing the diabetic patients who required mechanical ventilation or ICU admission or died versus the diabetic patient who did not. This meta-analysis did not calculate the risk of severity or mortality between patients with diabetes versus non-diabetic cohort.

Therefore, the conclusion of this meta-analysis should be that "patients who have severe COVID-19, or who die from the disease, are more likely to have diabetes", rather than diabetic patients had more severe Covid-19 and more likely to succumb to death. This needs to be clarified. There are number of meta-analysis now available We appreciate the keen interest taken by Drs. Singh and Singh for sending a correspondence in response to our article titled "Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis" [1] . The authors have raised three questions in the correspondence, mainly related to the methodology of our meta-analysis and the conclusion. Our reply to their questions is given below:

1. The authors have questioned why we have used odds ratio instead of risk ratio or hazard ratio as the effect size for association of diabetes with severity and mortality of COVID-19. However, the authors failed to note that all the included studies in our meta-analysis were retrospective case-control studies, in which the outcome of interest (mortality/severity) had already occurred. In case-control studies only odds ratio can be calculated, and relative risk cannot be calculated. For calculating relative risk cohort studies are more suitable which gives the incidence of the outcome in both the cohorts [2] . Similarly we could not use hazard ratio (which is also a type of relative risk) because in case-control studies time-to-event analysis is usually not there.

2. The authors have raised the doubt that many of the included studies would have overlapping patient data. However, the authors have failed to note that in the method section as well as in the discussion, we have diligently tried to avoid including any duplicate studies by limiting our search to single database, limiting search to English articles only, and carefully going through each included article's study setting and author list. We do agree that there could have been still some overlapping patients from USA in the CDC study [3] and from China in the study by Guan et al [4] , however, in our large meta-analysis of 16,003 patients, this small overlap is inevitable and inconsequential.

is associated with a two-fold increase in mortality as well as severity of COVID-19, as compared to non-diabetics"; and have suggested that we should have concluded as "patients who have severe COVID-19, or who die from the disease, are more likely to have diabetes". The reason for their objection is that we have calculated the odds ration and not the relative risk. While we partially agree with the change of wording as suggested by the authors; however, when the outcome of interest is rare, as the case of mortality/severity in patients with COVID-19, the odds ratio is very close to the relative risk [5] , and our conclusion will still hold good.

We would like to reiterate that until we have large cohort studies available which provides relative risk of severity/mortality of COVID-19 in diabetic patients versus non-diabetic patients; as of now, our meta-analysis gives the best estimate of the association between severe/fatal COVID-19 and diabetes. Moreover, the implication of our meta-analysis that the diabetic population needs to be protected from COVID-19 infection, and if infected, needs closer monitoring for severe diseases and adverse outcome, cannot be overemphasized. 

Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis

Understanding the odds ratio and the relative risk

Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 -United States

Clinical Characteristics of Coronavirus Disease 2019 in China

The relative merits of risk ratios and odds ratios

We hereby declare that we have no conflict of interest, related to this document.

Ritu Singh